EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

Combined acupuncture and cognitive behavioral therapy for major depressive disorder: study protocol for a randomized controlled trial

Molin Jiang, Zengqi Man, Jing Hu, Jing Yang, Hui Shen, Yuxian Wang, Qingnan Fu, Yang Li, Hengjia Liu, Zhengqing Shi, Wei Lu

Frontiers in Public Health · 18.11.2026 · 14

DOI: 10.3389/fpubh.2026.1925554 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Public Health, online erschienen am 18.11.2026. Verfasst von Molin Jiang und 10 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major depressive disorder (MDD) is a serious mental health condition. Although pharmacotherapy is the first-line treatment, its use is often limited by side effects and inadequate response. Acupuncture has demonstrated beneficial effects for MDD, and cognitive-behavioral therapy (CBT) is a guideline-recommended psychotherapy. Combining acupuncture with CBT may address both the physiological and psychological aspects of MDD, potentially enhancing therapeutic efficacy. We hypothesize that acupuncture plus CBT will yield superior clinical outcomes compared with antidepressant therapy alone in patients with mild-to-moderate MDD. Methods/design This trial is designed to compare combined acupuncture and CBT with sertraline for mild-to-moderate MDD, using an 8-week treatment period followed by a 16-week follow-up to evaluate clinical efficacy and safety. A total of 104 patients will be enrolled and randomly assigned in a 1:1 ratio to either the acupuncture combined with CBT group or the control group. The primary outcome is the response rate as measured by the 17-item Hamilton Depression Rating Scale (HAMD-17). Secondary outcomes include the remission rate, HAMD-17 scores, Quick Inventory of Depressive Symptomatology–Self-Report (QIDS-SR) scores, Patient Health Questionnaire-15 (PHQ-15) scores, Sheehan Disability Scale (SDS) scores, and performance on the THINC-it tool. Safety will be assessed using Side Effect Rating Scale (SERS) scores. Adverse events (AEs) will be recorded whenever they occur during treatment.

Discussion

Traditional Chinese medicine (TCM) views the mind and body as an integrated whole and therefore advocates for the concurrent regulation of psychological and somatic processes. Integrating acupuncture with CBT may offer comprehensive benefits for MDD, but high-quality comparative studies against antidepressants are lacking. As an exploratory trial, these findings will provide preliminary evidence to evaluate the role of the combined acupuncture and CBT approach in treating MDD. Clinical trial registration http://Itmctr.Ccebtcm.Org.Cn , identifier ITMCTR2024000653.

Zitieren

APA

Jiang, M., Man, Z., Hu, J., Yang, J., Shen, H., Wang, Y., Fu, Q., Li, Y., Liu, H., Shi, Z., & Lu, W. (2026). Combined acupuncture and cognitive behavioral therapy for major depressive disorder: study protocol for a randomized controlled trial. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1925554

Vancouver

Jiang M, Man Z, Hu J, Yang J, Shen H, Wang Y, et al. Combined acupuncture and cognitive behavioral therapy for major depressive disorder: study protocol for a randomized controlled trial. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1925554

BibTeX
@article{Jiang2026,
  author = {Jiang, Molin and Man, Zengqi and Hu, Jing and Yang, Jing and Shen, Hui and Wang, Yuxian and Fu, Qingnan and Li, Yang and Liu, Hengjia and Shi, Zhengqing and Lu, Wei},
  title = {Combined acupuncture and cognitive behavioral therapy for major depressive disorder: study protocol for a randomized controlled trial},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1925554}
}
Kostenlos starten →